Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The Prevalence of Pre-hypertension and Hypertension in an Iranian Urban Population

  • 72 Accesses

  • 7 Citations

Abstract

Objective

To determine the prevalence of hypertension and pre-hypertension and its determinants in the 40–64 year old population of Shahroud in the north of Iran.

Methods

The blood pressure of 5,190 of the 40–64 year old people participating in the first phase of Shahroud Eye Cohort Study was measured using the standard method. Sampling was done in 2009 using a random cluster approach. The prevalence of hypertension and pre-hypertension was determined by age and sex, and we used a multi-nominal logistic regression model to calculate the odds ratio (OR).

Results

The prevalence of pre-hypertension was 37.2 % in men and 30.9 % in women, and the prevalence of hypertension was respectively 37.1 % and 39.0 %. In both sexes, there was an increase in the prevalence of hypertension and a decrease in the prevalence of pre-hypertension with age. Older age, male sex, higher body mass index, blood glucose higher than 140 mg/dl were found associated with hypertension and pre-hypertension. Also, diabetes increases the odds of hypertension (OR = 1.4) and a history of smoking was correlated with a decreased odds of having hypertension and pre-hypertension.

Conclusion

According to the criteria of Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, the prevalence of hypertension and pre-hypertension was high in the studied population, and considering the epidemiologic transition of diseases in Iran, it can be concluded that a high percentage of the population are at risk of cardiovascular diseases.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–504.

  2. 2.

    Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord. 2007;7:32. doi:10.1186/1471-2261-7-32.

  3. 3.

    Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs. 2011;10(Suppl 2):S5–13.

  4. 4.

    World Health Organization. World health statistics 2012. Geneva: WHO; 2012. p. 34–7.

  5. 5.

    Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.

  6. 6.

    World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO; 2009.

  7. 7.

    Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–9.

  8. 8.

    Liszka HA, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005;3:294–9.

  9. 9.

    Abdollahy AA, Bazrafshan HR, Salehi A, Behnampour N, Hosayni SA, Rahmany H, Yazdi Kh, Sanagoo A. Epidemiology of hypertension among urban population in Golestan province in north of Iran. J Gorgan Univ Med Sci. 2007;8:37–41.

  10. 10.

    Farshidi H, Zare S, Boushehri E. Association between blood pressure changes and obesity in over-18 population of Bandar Abbas. Med J Hormozgan Univ. 2006;10:111–6.

  11. 11.

    Janghorbani M, Amini M, Gouya MM, Delavari A, Alikhani S, Mahdavi A. Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens. 2008;26:419–26.

  12. 12.

    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.

  13. 13.

    Hansen TW, Staessen JA, Zhang H, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens. 2007;20:483–91.

  14. 14.

    Lee JH, Hwang SY, Kim EJ, Kim MJ. Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers. Public Health Nurs. 2006;23:314–23.

  15. 15.

    Meisinger C, Doring A, Heier M. Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the monitoring trends and determinants of cardiovascular diseases/cooperative health research in the region of Augsburg cohort study. J Hypertens. 2008;26:1809–15.

  16. 16.

    Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:1682–6.

  17. 17.

    Yadav S, Boddula R, Genitta G, Bhatia V, Bansal B, Kongara S, Julka S, Kumar A, Singh HK, Ramesh V, Bhatia E. Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population. Indian J Med Res. 2008;128:712–20.

  18. 18.

    Janghorbani M, Amini M, Gouya MM, Delavari A, Alikhani S, Mahdavi A. Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens. 2008;26:419–26.

  19. 19.

    Pang W, Sun Z, Zheng L, Li J, Zhang X, Liu S, Xu C, Hu D, Sun Y. Body mass index and the prevalence of prehypertension and hypertension in a Chinese rural population. Intern Med. 2008;47:893–7.

  20. 20.

    Mullican D, Lorenzo C, Haffner S. Is prehypertension a risk factor for the development of type 2 diabetes? Diabetes Care. 2009;32:1870–2.

  21. 21.

    Agyemang C, Van Valkengoed I, Van Den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch in Amsterdam, the Netherlands: the SUNSET study. Eur J Cardiovasc Prev Rehabil. 2007;14:775–81.

  22. 22.

    Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36:1859–63.

  23. 23.

    Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med. 2004;164:2113–8.

  24. 24.

    Suri MF, Qureshi AI. Prehypertension as a risk factor for cardiovascular diseases. J Cardiovasc Nurs. 2006;21:478–82.

  25. 25.

    Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr. 2010;21:26–31.

  26. 26.

    Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, Kamgar M, Gouya MM, Abbasi M. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167. doi:10.1186/1471-2458-9-167.

  27. 27.

    Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, Lee KW, Cho KH, Yoon D, Baik SH, Choi DS, Kim SM. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006;24:1515–21.

  28. 28.

    Sun Z, Zheng L, Wei Y, Li J, Zhang X, Zhang X, Lis S, Xu C, Li J, Zhao F, Hu D, Sun Y. Prevalence and risk factors of the rural adult people prehypertension status in Liaoning Province of China. Circ J. 2007;71:550–3.

  29. 29.

    Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, Shyu YK. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005;23:1355–60.

  30. 30.

    Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164:2126–34.

  31. 31.

    Ghanbarian A, Madjid M, Rahmani M, Sarrafzadeh A, Azizi F. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran lipid and glucose study. Iran J Endocrinol Metab (IJEM). 2004;4:425–35.

  32. 32.

    Elliott WJ, Black HR. Prehypertension. Nat Clin Pract Cardiovasc Med. 2007;4:538–48.

  33. 33.

    Fotouhi A, Hashemi H, Shariati M, Emamian MH, Yazdani K, Jafarzadehpur E, Koohian H, Khademi MR, Hodjatjalali K, Kheirkhah A, Chaman R, Malihi S, Mirzaii M, Khabazkhoob M. Cohort profile: Shahroud Eye Cohort Study. Int J Epidemiol. 2012;. doi:10.1093/ije/dys161.

  34. 34.

    Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization technical report series 854. Geneva: WHO; 1995.

  35. 35.

    Mayo clinic. Type 2 Diabetes: tests and diagnosis. http://www.mayoclinic.com/health/type-2-diabetes/DS00585/DSECTION=tests-and-diagnosis.

  36. 36.

    American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(suppl 1):S11–66.

  37. 37.

    Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health. 2009;31:47–58.

  38. 38.

    Ferguson TS, Younger NO, Tulloch-Reid MK, Wright MB, Ward EM, Ashley DE, Wilks RJ. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord. 2008;8:20. doi:10.1186/1471-2261-8-20.

  39. 39.

    Delavari A, Horri N, Alikhani S, Gouya M, Mahdavi A, Hosseini S, Haghighi S, Amini P, Amini M. Prevalence of hypertension in Iranian urban and rural populations aged over 20 years in 2004. J Mazandaran Univ Med Sci. 2007;17:79–86.

  40. 40.

    Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–9.

  41. 41.

    Thamm M. Blood pressure in Germany—current status and trends. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 1999;61 Spec No:S90-3.

  42. 42.

    Bramlage P, Böhm M, Volpe M, Khan BV, Paar WD, Tebbe U, et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens. 2010;12(9):666–77.

  43. 43.

    Whyte JL, Lapuerta P, L’Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988–1994. J Clin Hypertens (Greenwich). 2001;3:211–6.

  44. 44.

    Campbell NR. Hypertension prevention and control in Canada. J Am Soc Hypertens. 2008;2:97–105.

  45. 45.

    Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, Mancia G, et al. Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension. J Hypertens. 2012;30:1065–74.

  46. 46.

    Jenei Z, Pall D, Katona E, Kakuk G, Polgar P. The epidemiology of hypertension and its associated risk factors in the city of Debrecen, Hungary. Public Health. 2002;116:138–44.

  47. 47.

    Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar MH, Khan AQ, Hattersley A, Schmid CH, Chaturvedi N. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens. 2003;21:905–12.

  48. 48.

    Kong C, Nimmo L, Elatrozy T, Anyaoku V, Hughes C, Robinson S, Richmond W, Elkeles RS. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis. 2001;156:373–8.

Download references

Acknowledgments

This project was supported by Noor Ophthalmology Research Center and Shahroud University of Medical Sciences.

Author information

Correspondence to Akbar Fotouhi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Khosravi, A., Emamian, M.H., Shariati, M. et al. The Prevalence of Pre-hypertension and Hypertension in an Iranian Urban Population. High Blood Press Cardiovasc Prev 21, 127–135 (2014). https://doi.org/10.1007/s40292-013-0035-y

Download citation

Keywords

  • Cardiovascular diseases
  • Epidemiology
  • Hypertension
  • Prehypertension
  • Iran